2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease
Heather L. Gornik(University of Pittsburgh Medical Center), Luke R. Wilkins(House of Representatives), José Antonio Sánchez Gutiérrez(Instituto Universitario General Gutiérrez Mellado), Lawrence B. Sadwin(House of Representatives), Thomas S.D. Getchius, Luke P. Brewster(House of Representatives), Diane Treat‐Jacobson(House of Representatives), Lori Byrd(House of Representatives), Mehdi H. Shishehbor, Scott Kinlay, Maya Serhal, Douglas E. Drachman, Debra Kohlman-Trigoboff, Eric A. Secemsky, Connie N. Hess(Brigham and Women's Hospital), Amy W. Pollak, Philip P. Goodney(Pitney Bowes (France)), Lee Kirksey(House of Representatives), Herbert D. Aronow, Jonathan K. Ehrman(House of Representatives), Shipra Arya(Arya Vaidya Sala), Karen J. Ho(Karen Hospital), Chandler A. Long(Duke Medical Center), Jennifer M. Eaves, Esther S.H. Kim, John N. Evans(House of Representatives), Beau M. Hawkins(University of Oklahoma Health Sciences Center), W. Schuyler Jones(Duke University), Venita Chandra(Radiance Technologies (United States)), Saher S. Sabri
Cited by 230
Related Papers
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
|New England Journal of Medicine|2017|851
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
|New England Journal of Medicine|2016|628